Howard County Council Member’s Run Toward State Seat Comes to End

sigaty

Mary Kay Sigaty, a veteran of local government, ran against State Delegate Clarence Lam for a seat in the Senate, but lost in the Democratic primary.

Howard County Council Chair Mary Kay Sigaty vied for the Democratic nomination for State Senate of Maryland’s District 12 in yesterday’s primary elections, but lost to Maryland State Delegate Clarence Lam.

In Howard County, Sigaty represents District 4, which, according to the Council’s website, includes parts of Columbia and is home to major employers such as the Johns Hopkins Applied Physics Lab, and the major concert venue, Merriweather Post Pavilion. Sigaty previously served on the Howard County Board of Education.

As described on Sigaty’s campaign website,

Mary Kay Sigaty has a long history of public involvement that includes serving the residents of Howard County as a three-term member of the County Council.  As a Council member, Mary Kay has served as the Chair of the Council, Zoning Board and Liquor Board.  She has worked on issues ranging from housing affordability, a living wage for Howard County workers, environmental sustainability and improving early childhood educational opportunities.

lam

Delegate Lam has represented District 12 in the House of Delegates since January 14, 2015. 

As described on Lam’s campaign website,

Clarence Lam, MD, MPH was elected to represent Maryland’s 12th Legislative District in 2014.  He currently serves on the House Appropriations   Committee, where he is assigned to the Health and Human Services Subcommittee and Oversight Committee on Pensions.  He was previously a member of the House Environment and Transportation Committee, including the Environment Subcommittee, Motor Vehicles & Transportation Subcommittee, and Land Use & Ethics Subcommittee.  As a legislator, he has served as a representative of the House of Delegates on the Maryland Electric Vehicle Infrastructure Council, the Commission on Environmental Justice and Sustainable Communities, and the Standing Advisory Committee on Opioid-Associated Disease Prevention and Outreach Programs.